2,155
Views
2
CrossRef citations to date
0
Altmetric
Original Articles

Exploring the impact of formulation and temperature shock on metered dose inhaler priming

, , &
Pages 84-90 | Received 04 Jul 2016, Accepted 19 Sep 2016, Published online: 14 Oct 2016

References

  • Church, T.K., Hargrave, G.K., Johnson, R., Lewis, D.A., O'Shea, H., and Versteeg, H.K. (2011). Visualising Dose Retention: Fluctuation on a pMDI Capillary Retention Model. Respir. Drug Deliv., 317–320.
  • Colombani, A.C., Chambers, F., Jansen, R., LeeK., and Hodson, D.J. (2010). Understanding the Cause of Increasing Dose Through Life from a Pressurized Metered Dose Inhaler (pMDI), in Respiratory Drug Delivery, R. N. Dalby, P. R. Byron, J. Peart, S. J. Farr, J. D. Suman, and P. M. Young, ed., Davies Healthcare International Publishing; River Grove, IL, pp. 425–430.
  • Fradley, G., and Hodson, D. (2008). Optimisation of Fluid Flow in pMDI Valves, in Respiratory Drug Delivery, R. N. Dalby, P. R. Byron, J. Peart, S. J. Farr, J. D. Suman, and P. M. Young, ed., Davies Healthcare International Publishing, River Grove, IL, vol. 2, pp. 329–332.
  • FDA Draft Guidance. (1998). Guidance for Industry (Draft). Metered dose inhaler (MDI) and dry powder inhaler (DPI) drug products: Chemistry, manufacturing, and controls documentation. Available at http://www.fda.gov/downloads/drugs/guidancecomplianceregulatoryinformation/guidances/ucm080584.pdf (Accessed 4 October 2016).
  • Flutiform Prescribing Information. (2016). Accessed May 09 Available from http://www.flutiform.com/sites/default/files/FLUTIFORM_MDI_PIL_UK.pdf (Accessed 9 May 2016).
  • Gamayunov, N.I., Uvarova, L.A., Malyshev, V.L., and Fel'dblyum, A. S. (1984). A Theory of Binary Liquid Mixture Evaporation from Capillaries. J. Eng. Phys. Thermophys., 46(3):317–321.
  • Lewis, D.A., O'Shea, H., and Church, T.K. (2011). Prediciting HFA-MDI dose Retention Properties: Engineering the Marriage between Canisters, Valves and Formulations. Respir. Drug Deliv. Eur., 2011(1):89–99.
  • Lewis, D. A., O'Shea, H., and Mason, F. (2016). Extending Metered Dose Inhaler Valve Prime Theory: The Effects of Formulation and Temperature Shock, in Respiratory Drug Delivery Europe, R. N. Dalby, P. R. Byron, J. Peart, S. J. Farr, J. D. Suman, P. M. Young, and D. Traini, eds., DHI Publishing, River Grove IL, pp. 71–78.
  • Myrdal, P. B., Sheth, P., and Stein, S. W. (2014). Advances in Metered dose Inhaler Technology: Formulation Development. AAPS Pharm. Sci. Tech., 15(2):434–455.
  • Newman, S., and Peart, J. (2009). Pressurized Metered dose Inhalers, in Respiratory Drug Delivery: Essential Theory and Practice, S. Newman, ed., Davies Healthcare International Publishing, River Grove, IL, Chapter 6.
  • Sharp, D.H. (1984). An Overview of Rayleigh-Taylor Instability. Physica D, 12:3–18.
  • Stein, S., Sheth, P., Hodson, P.D., and Myrdal, P. (2014). Advances in Metered dose Inhaler Technology: Hardware Development. AAPS Pharm. Sci. Tech., 15(2):326–338.
  • Thiel, C.G. (1996). From Susie's Question to CFC Free: An Inventors Perspective of Forty Years of MDI Development and Regulation, in Respiratory Drug Delivery V, R. N. Dalby, P R. Byron, and S. J. Farr, eds., Interpharm Press, Buffalo Grove, IL, pp.115–124.
  • Topliss, P., Ward, D., Southall, J.P., and Purewal, T.S. (2006). Pharmaceutical Performance of a Valve for Metered dose Inhalers (MDIs) Designed to Eliminate Loss of prime. Respiratory Drug Delivery, R.N. Dalby, P.R. Byron, J. Peart, S.J. Farr, and J.D. Suman, eds., DHI Publishing, River Grove, IL, pp. 499–502.
  • United States Pharmacopoeia. (2014). USP 37/NF32 Chapter 601: Inhalation and Nasal Drug Products: Aerosols, Sprays and Powders—Performance Quality Tests. USP Convention, Rockville, MD.
  • Wilby, M., Purkiss, G., Tilley, K., and Fradley, G. (2006). Novel Valve Designs to Eliminate Loss of Prime, In Respiratory Drug Delivery, R.N. Dalby, P.R. Byron, J. Peart, S.J. Farr, and J.D. Suman, eds., DHI Publishing, River Grove, IL, pp. 373–376.